| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064805 Isolated nucleic acids, vectors and host cells encoding ErbB3 antibodies |
| 05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
| 05/30/2002 | US20020064785 Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy |
| 05/30/2002 | US20020064784 Monitoring drug binding activity; obtain cells, generate mutation in cell genome, detect killing mutation, recover protein generated |
| 05/30/2002 | US20020064522 Activated hemicellulose as active ingredient; use as anticancer agents |
| 05/30/2002 | US20020064516 Pharmaceutical compositions comprising TGF-beta |
| 05/30/2002 | US20020064515 Administering synergistic mixtures of immunostimulatory CpG oligonucleotides with unmethylated cytosine and guanine in given sequence, and immunopotentiating cytokines; treating tumors; contraceptive |
| 05/30/2002 | CA2434760A1 Differentiated cells suitable for human therapy |
| 05/30/2002 | CA2430113A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |
| 05/30/2002 | CA2430037A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 05/30/2002 | CA2429976A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | CA2429712A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | CA2429649A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | CA2429647A1 Use of thienopyrimidines |
| 05/30/2002 | CA2429645A1 Use of pyrazolo[4,3-d]pyrimidines |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429570A1 Pyrimidine derivatives |
| 05/30/2002 | CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | CA2429368A1 Production of stilbenes in transgenic plants and the method of producing thereof |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | CA2428470A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2427661A1 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | CA2427340A1 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/30/2002 | CA2427184A1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 05/30/2002 | CA2426939A1 Cystoskeleton-associated proteins |
| 05/30/2002 | CA2426601A1 Cyanoguanidine prodrugs |
| 05/30/2002 | CA2398924A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 05/29/2002 | EP1209226A2 Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70) |
| 05/29/2002 | EP1208852A1 Neuropeptide Y1 receptor binding compounds in the treatment and diagnosis of cancer |
| 05/29/2002 | EP1208840A2 Combination of fluorouracil and a methylol transfer agent for the treatment of tumor metastases and cancer |
| 05/29/2002 | EP1208381A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 05/29/2002 | EP1208380A2 Cancer associated antigens and uses therefor |
| 05/29/2002 | EP1208234A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 05/29/2002 | EP1208228A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 05/29/2002 | EP1208218A2 Methods and compositions for delivery of pharmaceutical agents |
| 05/29/2002 | EP1208217A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208197A1 Iren protein, its preparation and use |
| 05/29/2002 | EP1208195A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
| 05/29/2002 | EP1208116A2 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 05/29/2002 | EP1208115A2 Feline interleukin-12 as an immune stimulant |
| 05/29/2002 | EP1208113A2 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties |
| 05/29/2002 | EP1208110A1 Antisense modulation of focal adhesion kinase expression |
| 05/29/2002 | EP1208104A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
| 05/29/2002 | EP1208097A2 Substituted oxoazaheterocyclyl compounds |
| 05/29/2002 | EP1208096A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 05/29/2002 | EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 05/29/2002 | EP1208088A2 Fluorene derivatives as integrin inhibitors |
| 05/29/2002 | EP1208086A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 05/29/2002 | EP1208085A2 Benzanilides as potassium channel openers |
| 05/29/2002 | EP1207906A1 Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-cd20 antibodies |
| 05/29/2002 | EP1207904A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 05/29/2002 | EP1207897A2 Pharmaceutical compositions containing tripeptides |
| 05/29/2002 | EP1207890A2 Antiviral prodrugs |
| 05/29/2002 | EP1207888A2 Use of paclitaxel and of steroid derivatives as aromatase inhibitors for the treatment of cancer |
| 05/29/2002 | EP1207881A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 05/29/2002 | EP1207876A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 05/29/2002 | EP1207875A1 Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 05/29/2002 | EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy |
| 05/29/2002 | EP1207755A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 05/29/2002 | EP1061812A4 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 05/29/2002 | EP0991637B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 05/29/2002 | EP0938329B1 Immunogenic tlp composition |
| 05/29/2002 | EP0889971B1 Phosphatase modulator |
| 05/29/2002 | DE10058663A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen |
| 05/29/2002 | DE10058662A1 Verwendung von Pyrazolo[4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
| 05/29/2002 | DE10057976A1 Verfahren zur Herstellung von Pektinhydrolyseprodukten A process for producing pectin hydrolysis products |
| 05/29/2002 | CN1351661A Compounds |
| 05/29/2002 | CN1351656A Human liver progenitors |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 05/29/2002 | CN1351602A New pharmaceutically active compounds |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351594A Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351589A Vitamin D analogues and their pharmaceutical use |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/29/2002 | CN1351587A Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 05/29/2002 | CN1351498A Pyrrolotriazines inhibitors of kinases |
| 05/29/2002 | CN1351494A Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 05/29/2002 | CN1351490A Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 05/29/2002 | CN1351081A Human protein with cancer cell growth suppressing function and its coding sequence |
| 05/29/2002 | CN1351080A Human protein with cancer call growth suppressing function and its coding sequence |
| 05/29/2002 | CN1351079A Human protein with cancer cell growth suppressing function and its coding sequence |
| 05/29/2002 | CN1350865A Keai Dan and its preparing process |
| 05/29/2002 | CN1350861A Process for preparing health-care oral liquid to prevent cancer and delay sanility |
| 05/29/2002 | CN1350853A Medicine for nourishing vital energy and blood and its preparing process |
| 05/29/2002 | CN1350845A Medicine for treating chronic granulocytic leukemia |
| 05/29/2002 | CN1350842A Lipoid and its application in medicines |
| 05/29/2002 | CN1085672C Phospholipid derivatives of phosphono-carboxylic acids, prodn, and use as antiviral |
| 05/29/2002 | CN1085666C 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyro sine kinase medicated cellular proliferation |
| 05/28/2002 | US6395886 Anticancer agents |